Navigation Links
Prostate cancer drug not found cost-effective

Taxotere which is the choice of drug for patients suffering from prostate cancer may not anymore have their choice to choose this drug as the Scottish Medicines Consortium (SMC) is of the view that the drug is very expensive and it does not have much effect on prostate cancer making it an expensive not so effective cancer drug//.

Doctors who were using the drug feel that the drug had shown very good effect in reducing tumor burden in these patients and has definitely prolonged and improved the lives of prostate cancer patients.

John Neate, Prostate Cancer Charity said, "This decision is very bad news for men in Scotland. I urge the SMC to review its position as the drug is regarded by many doctors as the treatment of choice as Taxotere is the only drug proven through rigorous trials to offer improved survival and quality of life to men with prostate cancer at this stage of their illness.”

Cancer consultant David Dodds, Beatson Oncology Centre Glasgow said, "Taxotere not only gives advanced prostate cancer patients more time, it also offers them opportunity to live fuller, more active and less painful, lives.

Scottish Medicines Consortium said, "The SMC advises NHS boards and area drug and therapeutic committees (ADTCs) that docetaxel in combination with prednisolone is not recommended for use within NHS Scotland for the treatment of patients with metastatic hormone refractory prostate cancer (MHRPC)”.

Source: BBC News.
'"/>




Page: 1

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
3. New Prostate Cancer Vaccine Shows Promise
4. Hormone Therapy applicable for Prostate Cancer
5. Prostate cancer and Vitamins
6. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
7. Early Detection Of Prostate Cancer
8. Awareness increase Prostate cancer detection
9. Better Prostate Cancer Test
10. Stopping Prostate Cancer from Spreading
11. Drug might prevent Prostate Cancer Spread
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the ... dispensaries and head shops –can’t help but be heartened by the industry’s current surge. ... odor aptly described as “skunk smell.” At last they can simply, safely and ...
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better place in South ... special report in the May issue of Consumer Reports focused on heart health. ... results achieved during and after coronary bypass and aortic valve replacement procedures. , ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG ... Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national ... which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... As part ... Museum today to honor the victims of the Holocaust and Nazi persecution, Center ... at Hadamar and Auschwitz on its CMATH Champions trip to Germany and Poland next ...
(Date:4/24/2017)... ... ... The California Dental Association Foundation’s two-day volunteer dental clinic, CDA Cares ... April 22-23 event at the San Mateo Event Center. , In addition to ... Cares educates the public and policymakers about the importance of good oral health and ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 The Global Effective Microorganisms (EM) ... report has covered and analysed the potential of Global Effective ... size, shares and growth factors. The report identifies and analyses ... in the global market. ... Browse 152 Tables and Figures, 6 Major Company Profiles, spread ...
(Date:4/19/2017)... , April 19, 2017 ... an immune response in pets such as canine, ... are of various types such as Attenuated Live ... Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated live ... virus or bacteria, which have been weakend under ...
(Date:4/19/2017)... , April 19, 2017  Novartis today ... the National Heart, Lung, and Blood Institute (NHLBI) ... that 58% of patients with treatment-naïve severe aplastic ... when treated with eltrombopag at the initiation of ... The study evaluated three sequential treatment groups, or ...
Breaking Medicine Technology: